Angiogenesis Genotyping and Clinical Outcome During Regorafenib Treatment in Metastatic Colorectal Cancer Patients

Scientific Reports - United Kingdom
doi 10.1038/srep25195
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Factors Associated With Regorafenib Adherence With Metastatic Colorectal Cancer

Patient Preference and Adherence
PharmacologyHealth PolicyMedicineToxicologySocial SciencesPharmaceutics
2019English

Large‐Scale, Prospective Observational Study of Regorafenib in Japanese Patients With Metastatic Colorectal Cancer in a Real‐World Clinical Setting

Oncologist
Cancer ResearchMedicineOncology
2019English

Regorafenib Adjusted Dose for Chilean Patients With Chemoresistant Metastatic Colorectal Cancer: A Case Series

ecancermedicalscience
Cancer ResearchOncology
2018English

Biomarker Signatures Correlate With Clinical Outcome in Refractory Metastatic Colorectal Cancer Patients Receiving Bevacizumab and Everolimus

Molecular Cancer Therapeutics
Cancer ResearchOncology
2015English

Safety and Efficacy of Regorafenib in Patients With Treatment-Refractory Metastatic Colorectal Cancer in Turkey: The Single-Arm, Open-Label REGARD Study

BMJ Open
Medicine
2020English

Real‐World Adherence in Patients With Metastatic Colorectal Cancer Treated With Trifluridine Plus Tipiracil or Regorafenib

Oncologist
Cancer ResearchMedicineOncology
2019English

A Systematic Review and Meta-Analysis of Retrospective Series of Regorafenib for Treatment of Metastatic Colorectal Cancer

Anticancer Research
MedicineCancer ResearchOncology
2017English

Regorafenib in Combination With Silybin as a Novel Potential Strategy for the Treatment of Metastatic Colorectal Cancer

Oncotarget
Oncology
2017English

KDR Gene as a Predictive Biomarker of Response to Regorafenib in Patients With Metastatic Colorectal Cancer (mCRC)

Journal of Pharmacogenomics & Pharmacoproteomics
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy